Home » TEVA TO COLLABORATE WITH NST ON CANCER TREATMENT
TEVA TO COLLABORATE WITH NST ON CANCER TREATMENT
Teva Pharmaceutical Industries Ltd. has signed a strategic cooperation agreement with NeuroSurvival Technologies (NST) of Petah Tikva for the development of a new treatment for cancer. The technology is based on the development of new molecular complexes, in turn based on original technology developed by NST, called ApoSense.
Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=1000067731&fid=942)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May